Meta-analysis of Optimal Patient Selection for Platinum-doublet Chemotherapy and Immune Checkpoint Inhibitor Combination Therapy in Non-small Cell Lung Cancer

Authors

Institutions

Publication Details

Journal
Haigan
Published
2025-10-20
DOI
https://doi.org/10.2482/haigan.65.901
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Meta-analysis of Optimal Patient Selection for Platinum-doublet Chemotherapy and Immune Checkpoint Inhibitor Combination Therapy in Non-small Cell Lung Cancer

Akihiro Imura, Hiroaki Ihara
Haigan
Cancer Immunotherapy and Biomarkers
article

Meta-analysis of Optimal Patient Selection for Platinum-doublet Chemotherapy and Immune Checkpoint Inhibitor Combination Therapy in Non-small Cell Lung Cancer

Akihiro Imura, Hiroaki Ihara
article en

Abstract

No abstract available for this paper.
HaiganVol. 65(6)
Shinmatsudo Central General Hospital (JP), Koto Hospital (JP)
Openalex Percentile: Top 57%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Meta-analysis of Optimal Patient Selection for Platinum-doublet Chemotherapy and Immune Checkpoint Inhibitor Combination Therapy in Non-small Cell Lung Cancer — Akihiro Imura, Hiroaki Ihara · Haigan (2025) | TGRS Research Map | TGRS